Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
with an emphasis on translational application and therapeutic development. The Cornea Biology Laboratory, under the direction of Sophie Deng, MD, PhD, studies corneal stem cells aiming to develop novel
-
of scientific publications in relevant fields. Experience with models of myopathies or inflammation. Familiarity with stem cell-derived muscle models or 3D culture systems (including physiological
-
Supervisor: prof. RNDr. Robert Vácha, PhD. Topic title: Designing Coiled-Coil Peptides for Controlled Membrane Fusion and Intracellular Delivery Annotation: Most approved drugs act on cell-surface targets
-
Supervisor: prof. RNDr. Robert Vácha, PhD. Topic title: Overcoming the Endosomal Barrier: Design Principles of Fusogenic Proteins for Lipid Vesicles Annotation: Cancer remains one of the leading causes
-
- and stem cell biology, and great synergy with renowned research groups. More information on the IMMENS and open positions available at the Åbo Akademi University in Turku can be found here: https
-
to identify candidate disease-causing variants. You will develop model systems, e.g. genome-editing of immune or induced pluripotent stem cells (iPSC) with specific patient-derived genetic variants. We aim
-
initiation and progression. This work has recently expanded to include investigations into how metabolism and autophagy influence the biology of embryonic and cancer stem cells. For more information about our
-
an active role in shaping future research directions. Applicants should hold (or be close to completing) a PhD in molecular biology, stem cell biology, genetics or a related discipline, with strong technical
-
include: immunology/inflammation, ß-cell biology, insulin resistance, and stem research. The appointee will occupy space in the Diabetes Center on the Parnassus campus of UCSF, and will be a member of the
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | 1 day ago
studies. The goals of the Rich Lab are to identify novel therapeutic paradigms in the treatment of advanced cancers, primarily malignant brain tumors, through the prism of stem cell biology to identify core